That said, I'm hoping Mr. Left is the one left when QCOR provides clinical trial updates, announces a small settlement or dismissal on the DOJ investigation and beats on EPS in Q4. Or in military cadence: your left, your left, your left, right, left.
FTC. DOJ. CMS, SEC.
The federal agency Mr. Left has not yet named as a QCOR adversary is Homeland Security.
So now we know what to expect next.
Meanwhile the fact: QCOR is under investigation by the DOJ for marketing practices--that's it, that's all, and that will almost certainly be a bump in the road somewhere in or after 2015, if any impact at all. Anything else is an informal inquiry which these agencies splash out by the dozen, because it is their job to make inquiries. No inquiries, no jobs. If I worked at the FTC, I would be making inquiries, lots of inquiries.